Chemistry: molecular biology and microbiology – Animal cell – per se ; composition thereof; process of... – Primate cell – per se
Reexamination Certificate
2011-06-28
2011-06-28
Wehbe, Anne Marie S (Department: 1633)
Chemistry: molecular biology and microbiology
Animal cell, per se ; composition thereof; process of...
Primate cell, per se
C435S325000
Reexamination Certificate
active
07968336
ABSTRACT:
The present invention is directed to pluripotent fetal stem cells derived from chorionic villus, amniotic fluid, and placenta and the methods for isolating, expanding and differentiating these cells, and their therapeutic uses such as manipulating the fetal stem cells by gene transfection and other means for therapeutic applications.
REFERENCES:
patent: 5580724 (1996-12-01), Alter
patent: 5646004 (1997-07-01), Van Vlasselaer
patent: 5665557 (1997-09-01), Murray et al.
patent: 5672346 (1997-09-01), Srour et al.
patent: 5677136 (1997-10-01), Simmons et al.
patent: 5744347 (1998-04-01), Wagner et al.
patent: 5750339 (1998-05-01), Smith
patent: 5827735 (1998-10-01), Young et al.
patent: 5827742 (1998-10-01), Scadden
patent: 5840502 (1998-11-01), Van Vlasselaer et al.
patent: 5861315 (1999-01-01), Nakahata
patent: 5965437 (1999-10-01), Scadden
patent: 6200806 (2001-03-01), Thomson
patent: 6242579 (2001-06-01), Lawman et al.
patent: 6455678 (2002-09-01), Yin et al.
patent: 6461645 (2002-10-01), Boyse et al.
patent: 6555318 (2003-04-01), Keller et al.
patent: 6555324 (2003-04-01), Olweus et al.
patent: 2001/0046489 (2001-11-01), Habener et al.
patent: 2001/0049139 (2001-12-01), Lagasse et al.
patent: 2001/0051372 (2001-12-01), Yin et al.
patent: 2002/0028510 (2002-03-01), Sanberg et al.
patent: 2002/0090722 (2002-07-01), Dominko et al.
patent: 2002/0090723 (2002-07-01), Carpenter et al.
patent: 2002/0123141 (2002-09-01), Hariri
patent: 2002/0142457 (2002-10-01), Umezawa et al.
patent: 2002/0160510 (2002-10-01), Hariri
patent: 2002/0164307 (2002-11-01), Habener et al.
patent: 2002/0168763 (2002-11-01), Yan et al.
patent: 2002/0187548 (2002-12-01), Keller et al.
patent: 2003/0017587 (2003-01-01), Rader et al.
patent: 2003/0022825 (2003-01-01), Nishikawa et al.
patent: 2003/0235563 (2003-12-01), Strom et al.
patent: 95/26507 (1995-10-01), None
patent: WO 97/41224 (1997-11-01), None
patent: 98/20731 (1998-05-01), None
patent: WO 00/73421 (2000-12-01), None
patent: 01/30980 (2001-05-01), None
Huss Stem Cells 18:1-9, 2000.
Kaufman et al. (2001) PNAS vol. 98, 10716-10721.
Thomson et al. (1998) Science, vol. 282, 1145-1147.
Campagnoli et al., “Identification of mesenchymal stem cells in human first trimester blood, liver, and bone marrow.” Blood 96:Abstract, 2000.
Shamblott, M. J. et al., “Derivation of pluripotent stem cells from cultured human primordial germ cells.” PNAS 95:13726-13731, 1998.
Qian, Ye et al.: “Recovery of Placental-Derived Adherent Cells with Mesenchymal Stem Cell Characteristics,”Blood, W.B. Saunders Company, Orlando, Fl, US, vol. 98, No. 11, Part 2, Dec. 7, 2001, p. 147B, XP009026843, ISSN: 0006-4971.
De Coppi, Paolo et al.: “Human Fetal Stem Cell Isolation from Amniotic Fluid for Tissue Reconstruction”Journal of Urology, vol. 167, No. 4 Supplement, Apr. 2002, p. 85, XP009057017 & Annual Meeting of the American Urology Association, Inc.; Orlando, Fl, USA; May 25-30, 2002, ISSN: 0022-5347.
Sharkey, A.M. et al.: “Expression ofC-Kit and Kit Ligand at the Human Maternofetal Interface,”Cytokine, vol. 6, No. 2, 1994, pp. 195-205, XP002354029, ISSN: 1043-4666.
Saito, Shigeru et al.: “Localization of Stem Cell Factor (SCF) and C-Kit mRNA in Human Placental Tissue and Biological Effects of SCF on DNA Synthesis in Primary Cultured Cytotrophoblasts,”Biochemical and Biophysical Research Communications, vol. 205, No. 3, 1994, pp. 1762-1769, XP002354030, ISSN: 0006-291X.
Kauma, Scott et al.: “The Expression of Stem Cell Factor and Its Receptor, C-Kit in Human Endometrium and Placental Tissues During Pregnancy,”Journal of Clinical Endocrinology and Metabolism, vol. 81, No. 3, 1996, pp. 1261-1266, XP002354028, ISSN: 0021-972X.
Pittenger, M.F., et al.: “Multilineage Potential of Adult Human Mesenchymal Stem Cells”,Science, American Association for the Advancement of Science, US, vol. 284, No. 5411, Apr. 2, 1999, pp. 143-147, XP000867221, ISSN: 0036-8075.
Branick et al., “Stem Cell Research: Licit or Complicit?”Health Progress80(5):37-42 (1999).
Campagnoli et al., “Circulating Hematopoietic Progenitor Cells in First Trimester Fetal Blood,”Blood95(6):1967-1972 (2000).
Craven et al., “Review: Transfusion of Fetal Cord Blood Cells: An Improved Method of Hematopoietic Stem Cell Transplantation?”J. Repro. Immun. 42:59-77 (1999).
Erlich et al., “Fluorescence-Based Selection of Gene-Corrected Hematopoietic Stem and Progenitor Cells From Acid Sphingomyelinase-Deficient Mice: Implications for Niemann-Pick Disease Gene Therapy and the Development of Improved Stem Cell Gene Transfer Procedures”Blood93(1):80-86 (1999).
Hall et al., “Phenotype Differentiation of TGF-β1 -Responsive Pluripotent Premesenchymal Prehematopoietic Progenitor (P4 Stem) Cells from Murine Bone Marrow,”J. Hematotherapy&Stem Cell Research10:261-271 (2001).
Heidari et al., “Promotion of Proliferation of Murine Hematopoietic Stem Cells by Growth Factors in Murine Amniotic Fluid,”J. Repro. Immun. 31:51-64 (1996).
Horie et al., “The Expression ofc-kitProtein During Oogenesis and Early Embryonic Development,”Biol. Reprod. 45(4) 547-552 (1991).
Ikuta et al., “Evidence That Hematopoietic Stem Cells Express Mousec-kitBut Do Not Depend on Steel Factor for Their Generation,”PNAS89:1502-1506 (1992).
Ogawa et al., “Expression and Function of c-Kit in Fetal Hematopoietic Progenitor Cells: Transition From the Early c-Kit-Independent to the Late c-Kit-Dependent Wave of Hematopoiesis in the Murine Embryo,”Development117:1089-1098 (1993).
Ohkubo et al., “High-Efficiency Retroviral Transduction of Fetal Liver CD38-CD34++ Cells: Implications for In Utero and Ex Utero Gene Therapy,”Fetal Diagn. Ther. 16:299-307 (2001).
Ohneda et al., “Hematopoietic Stem Cell Maintenance and Differentiation Are Supported by Embryonic Aorta-Gonad-Mesonephros Region-Derived Endothelium,”Blood92(3):908-919 (1998).
Priest et al., “Origin of Cells in Human Amniotic Fluid Cultures”Laboratory Investigation39(2):106-109 (1978).
Yamaguchi et al., “Umbilical Vein Endothelial Cells are an Important Source of c-kit and Stem Cell Factor Which Regulate the Proliferation of Haemopoietic Progenitor Cells”Br. J. Haematology94:606-611 (1996).
Ikuta, K. and Weissman, I.L., Proc Natl Acad Sci USA, 89:1502-1506 (1992). “Evidence that hematopoietic stem cells express mouse c-kit but do not depend on steel factor for their generation.”
Atala Anthony
De Coppi Paolo
Children's Medical Center Corporation
Nixon & Peabody LLP
Wehbe Anne Marie S
LandOfFree
Methods of isolation, expansion and differentiation of fetal... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of isolation, expansion and differentiation of fetal..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of isolation, expansion and differentiation of fetal... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2681662